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Abstract A major clinical need exists for cartilage repair
and regeneration. Despite many different strategies having
been pursued, the identification of an optimised cell type
and of pre-treatment conditions remains a challenge. This
study compares the cartilage-like tissue generated by human
bone marrow stromal cells (HBMSCs) and human neonatal
and adult chondrocytes cultured on three-dimensional (3D)
scaffolds under various conditions in vitro and in vivo with
the aim of informing future cartilage repair strategies based
upon tissue-engineering approaches. After 3 weeks in vitro
culture, all three cell types showed cartilage-like tissue
formation on 3D poly (lactide-co-glycolide) acid scaffolds
only when cultured in chondrogenic medium. After 6 weeks
of chondro-induction, neonatal chondrocyte constructs re-
vealed the most cartilage-like tissue formation with a
prominent superficial zone-like layer, a middle zone-like
structure and the thinnest fibrous capsule. HBMSC con-
structs had the thickest fibrous capsule formation. Under
basal culture conditions, neonatal articular chondrocytes
failed to form any tissue, whereas HBMSCs and adult
chondrocytes showed thick fibrous capsule formation at
6 weeks. After in vivo implantation, all groups generated
more compact tissues compared with in vitro constructs.
Pre-culturing in chondrogenic media for 1 week before
implantation reduced fibrous tissue formation in all cell
constructs at week 3. After 6 weeks, only the adult chon-
drocyte group pre-cultured in chondrogenic media was able
to maintain a more chondrogenic/less fibrocartilaginous
phenotype. Thus, pre-culture under chondrogenic condi-
tions is required to maintain a long-term chondrogenic phe-
notype, with adult chondrocytes being a more promising
cell source than HBMSCs for articular cartilage tissue
engineering.
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Introduction
Normal diarthrodial joint function requires the presence of
healthy articular cartilage capable of bearing mechanical
load. Damage to articular cartilage is of clinical concern
because of the limited ability of the tissue to self-repair
spontaneously (LeBaron and Athanasiou 2000a; Saha et al.
2011; Tuli et al. 2003). A number of clinical strategies have
been adopted over the years to tackle this problem, e.g.,
arthroscopic lavage and debridement, periosteum and
osteochondral transplantation, autologous chondrocyte im-
plantation (ACI) and free toe and joint to hand transfer but
each of these methods has its own disadvantages limiting
their use (Gu et al. 1997; Redman et al. 2005; Ringe and
Sittinger 2009; Tuan et al. 2003; Yang and Gu 2000). Over
the last decade, cell-based therapies have shown much
promise for articular cartilage regeneration; for example,
Brittberg et al. (1994) have reported the successful repair
of cartilage defects following autologous chondrocyte trans-
plantation. In 1995, Genzyme employed this technique to
develop “Carticel”, a Food and Drug Administration (FDA)-
approved ACI treatment for patients with cartilage injuries
of the knee. A major drawback of ACI is that it is a two-step
procedure in which cells are first harvested to allow for cell
expansion followed by a surgical procedure for the trans-
plantation of the expanded cells. The adverse effects of ACI
include arthrofibrosis, graft overgrowth and chondrosis
(Vasiliadis et al. 2010). Other associated problems with
chondrocyte transplantation are limited cell availability, loss
of re-differentiation capability in vitro and a risk of donor
site morbidity (Baksh et al. 2007). Moreover, no direct
evidence has been presented to date to suggest that ACI
treatment is superior to alternative surgical options such as
microfracture or mosaicplasty. Studies comparing the cost
effectiveness of ACI against that of mosaicplasty or
microfracture found insufficient difference of any signifi-
cance between the three procedures (Clar et al. 2005;
Rodriguez-Merchan 2012; Vasiliadis et al. 2010). On the
basis of these comparisons, experts have voiced the need for
more basic science research into determining factors that
help differentiate and maintain stem cells in a chondrogenic
phenotype (Clar et al. 2005). Thus, efforts are now focused
on stem cell therapy. Because of ethical issues and potential
problems in the regulation of cell differentiation in vivo, the
application of embryonic stem cells has been limited (Lin et
al. 2005). Wei et al. (2012) have reported the use of induced
pluripotent stem cells for chondrogenic differentiation.
However, their reprogramming may have the risk of gener-
ating germ cell tumours (Grad et al. 2011). Adult mesen-
chymal stem cells (MSCs) have become a popular
alternative for the treatment of cartilage injuries. MSCs are
said to have extensive self-renewal, long-term cell viability
and multi-lineage potential together with a lack of or mini-
mal immunogenicity (Lin et al. 2005). Adult stem cells
derived from a myriad of sources (bone marrow, fat pad,
synovial fluid, dental pulp and periosteum) have demon-
strated chondrogenic potential in vitro (Emans et al. 2005;
Estes et al. 2006; Johnstone et al. 1998; Shintani and
Hunziker 2007; Yanai et al. 2005). Some of these stem cells
have been used clinically to regenerate bone but their clin-
ical application in regenerating human cartilage is either
undocumented or in the early stages (Horwitz et al. 2002;
Wakitani et al. 2002). Whereas the numerous different types
of adult stem cells isolated have been documented to pos-
sess the typical stem cell markers (adherence to tissue cul-
ture plastic; expression of CD105, CD73 and CD90;
differentiation along chondro/osteo/adipogenic lineages),
these stem cell populations have diverse proliferation rates
and dissimilar differentiation potentials and respond differ-
ently to growth factors (Chen and Tuan 2008; Dominici et
al. 2006). The method of cell isolation, culture, medium,
growth factors, interaction with scaffold material and sub-
strate topography are all known to affect cell proliferation
and differentiation. However, different protocols are used by
different research groups, making it a challenge to compare
between different studies; thus, the optimum cell source and
culture conditions for use in cartilage tissue repair is yet to
be determined (Chen and Tuan 2008). To date, human bone
marrow MSCs (HBMSCs) remain the most studied and best
understood stem cell source used in cartilage tissue engi-
neering (Chen et al. 2005; Johnstone et al. 1998; Mackay et
al. 1998; Penick et al. 2005; Ponticiello et al. 2000; Wayne
et al. 2005; Yanai et al. 2005)
The fabrication of ex vivo three-dimensional (3D) carti-
lage constructs by using functional tissue-engineering ap-
proaches has been used in an attempt to solve clinical
problems of repair/regeneration of articular cartilage. The
outcomes of such studies have however yielded inconsistent
results (LeBaron and Athanasiou 2000a). We have previ-
ously compared HBMSCs, human adult chondrocytes and
human neonatal articular chondrocytes under various two-
dimensional (2D) culture conditions simulating the in vitro
stage of articular chondrocyte implantation therapy and have
reported intrinsic differences in the microenvironment of the
three cell types studied (Saha et al. 2010). In the present
study, we have seeded cells on the cartilage phase of a
TruFit CB (Smith & Nephew) scaffold. This scaffold is an
FDA-approved resorbable biphasic implant constituted
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predominantly from polylactide-co-glycolide copolymer
(PLGA), calcium sulphate and polycolide and has a mean
pore diameter of 250 μm (http://www.ortovit.eu/ortopedie/
special/doc/TruFit%20CB%20Plugs.pdf). The scaffold used
has been documented in the literature as successfully
supporting chondrocyte migration and the synthesis of
chondrogenic ground matrix and has yielded promising
clinical results (Agrawal and Stinson 2007; Williams and
Gamradt 2008). The present study builds on our previous
work and compares the genesis of 3D cartilage-like tissue in
vitro and in vivo by using the same three cell types as before
in an attempt to illustrate intrinsic differences between the
chondrogenic potential of a progenitor cell type and imma-
ture and mature chondrocytes, which represent the three
different life stages of a cartilage-forming cell and also to
identify an optimum cell type for use in cartilage tissue
engineering, thereby informing future cell therapy strategies
for cartilage repair.
Materials and methods
Passage 1 HBMSCs (two donors aged 38 and 40 years) and
primary adult chondrocytes (two donors aged 35 and
40 years) from haematologically normal donors were
obtained from Lonza (UK). Primary neonatal articular
chondrocytes (Passage 0) were provided by Smith &
Nephew (UK) with appropriate ethical approval and consent
for use in commercial and collaborative research. Alpha-
modified minimum essential medium (α-MEM) and fetal
calf serum (FCS) were from Lonza.
Cell culture
Cells were expanded in basal media (α-MEM with 10%
FCS) and the medium was changed every 3 days. The cells
were passaged at 70%–75% confluency up to a maximum of
passage 4. To induce chondrogenesis, a serum-free
chondrogenic medium consisting in α-MEM supplemented
with 10 ng/ml transforming growth factor beta 3 (TGF-β3:
Peprotech, USA), 10−8 M dexamethasone, 100 μM
ascorbate-2-phosphate and 1× insulin transferring selenium
supplement (Johnstone et al. 1998; Saha et al. 2010) was
used in place of the basal medium.
Dynamic seeding of cells on 3D scaffolds
In order to visualise cell attachment and spreading
on/within the scaffolds, the cells were labelled with
50 μg CellTracker Green 5-chloromethylfluorescein
diacetate (Invitrogen) in 5 ml α-MEM for 45 min (Yang
et al. 2006). The cells were trypsinised and 2.5×105 cells of
each cell type were seeded dynamically onto the separated
ultra-violet-sterilised cartilage phase of TruFit CB Plugs
(3×1.5 mm3) by using a dynamic seeding apparatus
designed in house (rotational speed: 17 rpm) for 24 h.
Optical sections of the cell-scaffold construct (up to a depth
of 300 μm) were obtained by confocal laser scanning
microscopy (CLSM; Leica). Images were stacked and 3D
reconstruction was carried out by using Leica confocal
software enabling us to visualise cell viability up to a
considerable depth within the scaffold.
In vitro static culture of cells on 3D scaffolds
After 24 h of dynamic seeding, the constructs were trans-
ferred to 24-well plates and cultured in vitro in either basal
or chondrogenic medium under static conditions at 37°C in
a humidified atmosphere of 5% CO2 (n=4). After 3 or
6 weeks, the constructs were fixed in 10% neutral buffered
formaldehyde (NBF) and embedded in paraffin. Sections
(5 μm thick) were prepared by using a Leica microtome.
In vivo intra-peritoneal implantation
All the in vivo studies were carried out under UK Home
Office project license and were approved by the University
of Leeds ethical committee. Briefly, cells were dynamically
seeded onto scaffolds as described above. Constructs were
then cultured in vitro in basal or chondrogenic media (n=4)
for a further 7 days and then sealed into diffusion chambers
(Millipore, UK) prior to intra-peritoneal implantation in
male immuno-compromised nude mice (MF1-Nu/Nu, 4–
5 weeks old; Partridge et al. 2002; Yang et al. 2004). After
3 or 6 weeks, the mice were killed in compliance with UK
Home Office regulations and the chambers removed and
fixed in 10% NBF at 4°C. Samples were then processed in
the same way as the in vitro samples.
Alcian Blue/Sirius Red staining
Alcian Blue/Sirius Red staining was used to visualise the
presence of sulphated glycosaminoglycans and collagen
within the constructs. Briefly, the sections were stained with
Weigert’s haematoxylin for 15 min prior to being stained
with 0.5% Alcian Blue for 10 min. After a 20-min treatment
with freshly prepared 1% molybdophosphoric acid, samples
were stained for up to 1 h in 0.3% Sirius Red. The sections
were then mounted in p-xylene bis-pyridinium bromide
(DPX) and observed under an Olympus BX50 microscope
by using SPOT software.
Immunohistochemical staining
Immunohistochemistry was carried out in order to assess the
expression of Sox9 (rabbit polyclonal anti-SOX9; Abcam)
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and aggrecan (mouse monoclonal anti-aggrecan; Abcam) in
5-μm-thick paraffin sections of the constructs retrieved after
culture in vitro and in vivo. Endogenous peroxidase activity
was blocked by using 3% hydrogen peroxide and an antigen
retrieval step was carried out by using an antigen unmasking
vector solution (Vector Laboratories, Calif., USA). Samples
were incubated in primary antibody (1/50 dilution of anti-
Sox9; 1/100 dilution of anti-aggrecan) for 1 h at room
temperature. The EnVision Kit, which contained the sec-
ondary antibody (Dako), was employed to detect peroxidase
activity. All samples were processed simultaneously to en-
sure homogeneity in the staining procedure. Samples tested
for the presence of Sox9 were counterstained in Fast Green
for 30 s. Negative controls (minus the primary antibody)
were also carried out for each sample. All samples were
dehydrated, cleared in xylene, mounted in DPX and ob-
served under an Olympus BX50 microscope by using
SPOT software. For any given 3D construct, consecutive
paraffin sections were used to assess the expression of the
different chondrogenic markers in order to minimise any
depth-dependent variations that may have arisen. A qualita-
tive assessment of the intensity of any immunostaining
observed was made.
Results
Cell attachment and spreading on 3D scaffolds
After 24 h of dynamic seeding, CLSM 3D reconstruction
images showed that the majority of cells of each cell type
were viable and had attached on all sides of the scaffolds
(Fig. 1). Cell morphology appeared to be stretched with
elongated processes clearly visible indicating cell spreading.
Cells were also observed to have penetrated into the central
part of the scaffold (ingrowth). No obvious differences were
noted between any of the cell types with respect to cell
viability, attachment and spreading.
Alcian Blue/Sirius Red staining of in vitro 3D
tissue-engineered constructs
Constructs cultured for 3 weeks in basal media in vitro re-
vealed only limited cell proliferation and extracellular matrix
(ECM) formation, confirmed by extremely faint Alcian Blue
staining for all three cell types (Fig. 2a–c). In contrast, intense
Alcian Blue staining (but not Sirius Red staining), together
with the appearance of cells aligned parallel to the surface
edge of the scaffold, was seen in the matrix of constructs
following chondrogenic culture. Again, this was similar for
all three cell types (Fig. 2d–f). After 6 weeks in basal medium,
HBMSCs and adult chondrocyte constructs contained areas
that stained intensely for Sirius Red (Fig. 2g, i) revealing a
fibrous capsule formation in the outermost layer of the
constructs.However, the matrix in the neonatal articular
chondrocyte constructs cultured in the same group failed
to stain intensely with Alcian Blue/Sirius Red because of
limited tissue formation (Fig. 2h). Under chondrogenic
culture conditions, constructs for all three cell types were
more cellular, with the presence of cells growing both
parallel and perpendicular to the construct surfaces. A
thick fibrous capsule was seen in the HBMSC constructs,
which stained strongly with Sirius Red staining (Fig. 2j).
In comparison, only limited Sirius Red staining was
observed in adult chondrocyte constructs, with neonatal
chondrocyte constructs having the thinnest fibrous cap-
sule of all three cell types observed (Fig. 2k, l).
Immunohistochemical analysis of 3D constructs cultured
in vitro
Sox9 was detected in all basal and chondro-induced con-
structs after both 3 weeks (Fig. 3a–f) and 6 weeks in vitro
(Fig. 3g–l) with chondro-induced adult chondrocytes
appearing to have visibly more Sox9-positive cells after
6 weeks in culture, although no further quantification was
preformed to confirm this observation (Fig. 3l). Similar
Fig. 1 Confocal images of
human bone marrow stromal
cells seeded onto TruFit
scaffolds. The cells were
labelled with live/dead
fluorescent markers (green
viable cells, yellow arrows
attachment of viable cells onto
all available areas of the 3D
scaffold). Bars 94.34 μm (a),
72.62 μm (b)
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immunostaining intensities for aggrecan were detected for
all three cell types cultured in either basal or chondrogenic
medium for 3 weeks. After 6 weeks in basal or chondro-
induced medium, all constructs appeared to have increased
amounts of aggrecan as evidenced by their higher staining
intensities compared to the respective 3-week constructs
(Fig. 4). The highest staining intensity for aggrecan was
observed at 6 weeks in the constructs containing adult
chondrocytes following chondro-induction, with a similar
pattern to that seen for Sox9 expression.
Alcian Blue/Sirius Red staining of in vivo 3D
tissue-engineered constructs
After 3 weeks of in vivo implantation, histological examina-
tion revealed that HBMSCs and adult and neonatal
chondrocytes formed a more compact neo-tissue (Fig. 5a–f)
compared with similar constructs generated in vitro
(Fig. 2a–f). However, constructs pre-cultured in basal medi-
um for a week before implantation had a dense anionic
matrix indicative of mucopolysaccharides accompanied by
fibrous capsule formation (Sirius Red positive) for all cell
types, with constructs containing neonatal articular
chondrocytes having formed the least amount of neo-tissue
(Fig. 5a–c). In contrast, pre-chondro-induced constructs for all
three cell types revealed the formation of a cartilage-like neo-
tissue with mainly Alcian Blue staining and little Sirius Red
staining at week 3 (Fig. 5d–f). After 6 weeks of in vivo
implantation, HBMSC and neonatal chondrocyte constructs
pre-cultured in basal medium appeared to be fragmented with
a limited amount of tissue being apparent (Fig. 5g, h).
Constructs containing adult chondrocytes did not appear
fragmented but had copious amounts of Sirius-Red-positive
staining (Fig. 5l). For the constructs pre-cultured in
chondrogenic medium, cartilage-like structures were seen af-
ter 6 weeks in vivo for all three cell types; however, a prom-
inent fibrous capsule had formed in the constructs containing
HBMSCs and neonatal articular chondrocytes (red staining in
Fig. 5j, k). In contrast, chondro-induced adult chondrocyte
constructs had little Sirius Red staining and lacked any evi-
dence of a prominent fibrous capsule after 6 weeks of in vivo
implantation (Fig. 5l).
Immunohistochemical analysis of 3D constructs cultured
in vivo
Sox9 was detected in both chondro-induced and non-
chondro-induced constructs after 3 and 6 weeks culture in
Fig. 2 Alcian Blue/Sirius Red
staining of in vitro static
cultured cell-scaffold
constructs. Histological
appearance of constructs
following basal culture for
3 weeks (a–c) and 6 weeks
(g–i) compared with that of
chondro-inductive culture for
3 weeks (d–f) and 6 weeks
(j–l). The constructs cultured in
chondrogenic media at 3 and
6 weeks stain more intensely for
Alcian Blue (arrows) in
comparison to constructs
cultured for similar time points
in basal media. Constructs
cultured for 6 weeks are much
more cellular than those
cultured for 3 weeks
(red/arrowheads Sirius Red
staining, BC basal culture, CC
chondrogenic culture, HBMSCs
human bone marrow stromal
cells). Bars 1 mm
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vivo (Fig. 6). Qualitatively, for each cell type, more Sox9-
positive cells appeared to be present in constructs pre-
cultured statically in chondrogenic medium than in those
pre-cultured in basal medium. Fewer Sox9-positive cells
were seen in the chondro-induced constructs for all cell
types after 6 weeks in vivo compared with chondro-
induced constructs cultured for 3 weeks in vivo. Strong
immuno-staining for aggrecan was evident in all of the in
vivo constructs with the highest staining intensities being
observed for chondro-induced neonatal and adult chondro-
cyte constructs implanted in vivo for 6 weeks (Fig. 7).
Discussion
Successful integration of engineered neocartilage with host
cartilage is the ultimate goal for cartilage repair. The hy-
pothesis behind functional cartilage tissue engineering is
that successful articular cartilage repair/regeneration will
involve the ex vivo synthesis of cartilaginous tissue
(LeBaron and Athanasiou 2000a). Differences in methodol-
ogies used by researchers to investigate cartilage repair have
led to conflicting results. No agreed consensus has been
reached concerning the ideal scaffold/cell source/regulatory
factors (mechanical stimuli and growth factors) best suited
for cartilage regeneration (Caplan and Dennis 2006;
LeBaron and Athanasiou 2000b) and the specific signalling
pathways that induce chondrogenesis remain generally un-
known (Kolf et al. 2007).
The success of any cell-based therapy depends upon the
selection of an appropriate cell source. Chondrocytes are an
obvious choice for de novo engineering of articular cartilage
and are used routinely in the clinic for ACI. The main
drawback to this approach lies in the need to produce a
homogeneous ECM that can theoretically be induced via
the application of appropriate biochemical and biomechan-
ical signals (Klein et al. 2009). In order to obtain a func-
tionally relevant tissue-engineered construct, we need to
understand tissue histogenesis occurring in vivo. In our
previous study, biochemical assays and gene expression
analysis of the cells in 2D culture were carried out under
conditions mimicking current cell processing methodologies
for ACI therapies in the clinic (Saha et al. 2010). In the
present study, we have compared the chondrogenic potential
of three human cell types, namely HBMSCs, neonatal artic-
ular chondrocytes and adult chondrocytes, in 3D constructs
in vitro and in vivo. Our primary goal has been to engineer
tissues with histological structures resembling those seen in
Fig. 3 Sox9
immunohistochemical staining
of in vitro statically cultured
cell-scaffold constructs. Sox9
immunohistochemical staining
of constructs following basal
culture for 3 weeks (a–c) and
6 weeks (g–i) compared with
that of chondro-inductive
culture for 3 weeks (d–f) and
6 weeks (j–l). All sample
constructs stained positively for
Sox9 (arrows, dark brown)
with qualitatively the highest
Sox9-positive cell staining
being observed for constructs
cultured in chondrogenic media
for 6 weeks (BC basal culture,
CC chondrogenic culture,
HBMSCs human bone marrow
stromal cells). Bars 1 mm
500 Cell Tissue Res (2013) 352:495–507
native cartilage, given the apparent importance of morpho-
logically distinct zones in the functioning of healthy articu-
lar cartilage (Klein et al. 2009). Ultimately, this work should
help to determine the optimum cell source and pre-treatment
conditions for ex vivo cartilage generation.
We are aware that the use of neonatal articular chondrocytes
as a cell source for cartilage tissue engineering has potential
ethical issues. We are not proposing their use as an alternative
cell source but have included them in this study because little is
known about the behaviour of neonatal articular chondrocytes
in culture. Furthermore, we feel that studying these cells
alongside mature cartilage cells and stromal cells will help
improve our understanding of the biology of chondrocytes
and illustrate key differences in the factors that are involved
in the differentiation/maintenance of a chondrogenic cell type.
In our previous study, for example, we showed differences in
temporal gene expression between neonatal articular
chondrocytes and the mature cells. In experiments that mim-
icked current cell processing methodologies in the clinic, our
previous work comparing neonatal articular chondrocytes and
the mature cell types indicated that signalling events occurred
during the first few days of chondrogenic culture prior to the
deposition and organisation of a hyaline cartilage ECM. We
also showed that the chondrogenic phenotype, which is a
balance between proteoglycan content and collagen integrity,
was regulated in a sequential/cyclic manner (Saha et al. 2010).
In order to induce chondrogenesis in vitro, we used
serum-free α-MEM chondrogenic medium containing
10 ng/ml TGF-β3 based upon its known chondro-
inductive properties (Alhadlaq et al. 2004; Darling and
Athanasiou 2003; Pittenger et al. 1999; Tare et al. 2005).
All three cell types were seeded onto the cartilage phase of
TruFit CB Plug scaffolds of 3 mm in diameter. Unlike most
synthetic scaffolds, TruFit CB Plug scaffolds can support
cell attachment and growth without surface modification
and promote the repair of osteochondral defects in vivo
(Agrawal and Stinson 2007; Williams and Gamradt 2008),
including the successful repair of an articular cartilage de-
fect in the human femoral condyle (Carmont et al. 2009).
Static seeding of cells onto the scaffold can result in a
clustering of cells at the periphery with an extremely low
cell density at the centre (Vunjak-Novakovic et al. 1998;
Wendt et al. 2003). A standard dynamic seeding apparatus
(17 rpm) designed and manufactured in-house was there-
fore employed to seed the cells onto the TruFit CB Plug
scaffolds and the results confirmed uniform cell viability
and cell density throughout the scaffolds for all three cell
types used. Following dynamic seeding, the constructs
Fig. 4 Aggrecan
immunohistochemical staining
of in vitro statically cultured
constructs. Aggrecan
immunohistochemical staining
of constructs following basal
culture for 3 weeks (a–c) and
6 weeks (g–i) compared with
that of chondro-inductive
culture for 3 weeks (d–f) and
6 weeks (j–l). All sample
constructs stained positively for
agrrecan (arrows, brown) with
qualitatively the highest
staining intensity being
observed in chondro-induced
adult chondrocyte samples
cultured for 6 weeks (BC basal
culture, CC chondrogenic
culture, HBMSCs human bone
marrow stromal cells). Bars
1 mm
Cell Tissue Res (2013) 352:495–507 501
were cultured statically to encourage compressive cell ad-
hesion (CCA).
After 3 weeks of in vitro culture in chondro-induced medi-
um, individual cells embedded in lacunae arranged parallel to
the periphery of the scaffolds were observed in all of the
constructs further supporting a cartilage-like phenotype. After
6 weeks in vitro, 3D chondro-induced constructs for all three
cell types visually appeared to be more cellular compared to
their 3-week counterparts. Intense Alcian Blue/Sirius Red
staining and pronounced zonal organisation similar to that seen
histologically for native articular cartilage (cells appeared flat-
tened and parallel to the surface, with larger rounder cells in the
middle-to-base area being aligned perpendicular to the surface)
were observed in constructs for all three cell types in
chondrogenic medium without any exogenous stimuli or
perfusion/diffusion of nutrients. Our results contradict those
reported by Seda Tigli and colleagues (2009) who detected
faint positive Safranin-O staining for all chondrocyte andMSC
constructs over 4 weeks of static chondrogenic culture on
chitosan and silk scaffolds, indicative of incomplete
chondrogenesis. In the current study, positive Alcian Blue
staining characteristic of glycosaminoglycans was seen for all
our cell constructs as early as 3 weeks in static chondrogenic
culture, indicating that a combination of any of the three cell
types with TGF-β3 and the PLGA TruFit CB Plug scaffold
would be suitable for the induction/short-term maintenance of
chondrogenesis. The most interesting observation was that, of
all the three cell types studied in vitro, neonatal articular
chondrocytes appeared to have formed the thinnest fibrous
capsule after 6 weeks of chondrogenic culture compared with
the mature cell types. However, the highest staining intensity
for Sox9 and aggrecan was observed in the constructs
containing chondro-induced adult chondrocytes at 6 weeks.
Most in vivo models used to study chondrogenesis are
implant models with the main drawback being apoptosis of
almost 85% of the implanted cells over a 4-week period
(Mierisch et al. 2003; Ostrander et al. 2001). The constructs
need first to undergo a period of CCA before in vivo
implantation, although highly mature constructs might fail
to integrate with the native tissue (Obradovic et al. 2001)
and a determination of the extent of in vitro maturation
before the 3D construct is placed in vivo is important. In
this study, after dynamic seeding onto the scaffold, the 3D
constructs were allowed to undergo a week of CCA in static
culture in either basal or chondro-induced medium before
implantation within diffusion chambers intra-peritoneally in
Fig. 5 Alcian Blue/Sirius Red
staining of cell-scaffold constructs
in vivo. After 1 week in vitro
culture in basal (a–c, g–i) and
chondro-inductive medium (d–f,
j–l), the cells and scaffolds were
sealed in diffusion chambers that
were implanted intra-peritoneally
in nude mice for 3 (a–f) or
6 weeks (g-l). Sirius Red staining
(arrowheads, red) indicates
collagenous matrix formation.
Alcian Blue staining (arrows,
blue) indicates the presence of
muccopolysaccharides in the
matrix. After 3 weeks of in vivo
implantation, the basal group
shows more fibrocartilage-like
tissue formation than samples pre-
cultured in chondro-inductive
medium. At 6 weeks,
fibrocartilage-like tissue formation
is observed in both HBMSCs and
neonatal chondrocyte constructs
pre-incubated in chondro-
inductive medium. In contrast,
adult chondrocytes of the same
culture group seem to retain their
cartilage-like tissue structure (BC
basal culture, CC chondrogenic
culture, HBMSCs human bone
marrow stromal cells). Bars 1 mm
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Nu/Nu mice. This time period was based on results from
real-time polymerase chain reaction analysis (Saha et al.
2010), which had previously indicated that signalling events
occur during the first few days of chondrogenic culture prior
to the deposition and organisation of an ECM of hyaline-
like cartilage.
The diffusion chamber model provides an enclosed space
within the host animal for studies of cellular proliferation/
differentiation without host versus donor tissue rejection
(Partridge et al. 2002; Yang et al. 2004). This model approaches
an in vivo bioreactor, since the chambers allow the diffusion of
nutrients within the peritoneal space similar to articular cartilage
in a joint, together with possible (albeit low level) biomechanical
loading. In this study, 3D construct samples of all three cell types
that were pre-incubated in basal medium formed comparable
fibrocartilage-like tissue within 3 weeks of in vivo implantation.
After 6 weeks, the adult chondrocyte construct group showed
the formation of highly organised fibrocartilage structures.
Interestingly, the neo-tissue generated by HBMSCs and neona-
tal articular chondrocytes under similar conditions lacked any
obvious structural organisation and the disorganised tissue was
limited. However, pre-incubation in chondrogenic medium was
seen to improve the cartilage-like characteristics of the neo-
tissue generated by all three cell types, with no fibrous tissue
formation discernable in any of the constructs at 3 weeks. Pre-
incubation in chondrogenic medium for 1 week might therefore
help maintain cell signalling pathways post-implantation.
Fibrocartilage-like tissue formation was, however, observed
after 6 weeks in vivo for both chondro-induced HBMSCs and
neonatal chondrocytes. In contrast, adult chondrocyte constructs
lacked evidence of any significant fibrous tissue formation and
the formed tissue tended to be more compact and had the
smallest fibrous capsule (as shown by Sirius Red staining).
The importance of stem cell condensation and homing is
now appreciated, making it imperative to be able to recapit-
ulate fully natal and postnatal development for a successful
tissue-engineering approach. In vitro chondrogenic induc-
tion has been documented to improve the quality of cartilage
genesis in vivo (Liu et al. 2007). A 7-day pre-incubation in
chondro-induced media has been observed to be sufficient
to sustain the chondrogenic phenotype for long-term culture
in adult chondrocytes. Perhaps prolonging the pre-
incubation period in vitro to 10–14 days before in vivo
implantation in the case of HBMSCs and neonatal articular
chondrocytes would yield a more hyaline-like tissue, even
after a long-term culture period.
We have built extensively on our previous research of
comparing and contrasting the chondrogenic potential of
Fig. 6 Sox9 immunostaining
of cell-scaffod constructs in
vivo. Positive staining for Sox9
(arrows, brown) was seen in
constructs after in vivo
implantation intra-peritoneally
in nude mice for 3 (a–f) or
6 weeks (g–l). Constructs pre-
cultured in chondrogenic media
stained more intensely for Sox9
compared with constructs pre-
incubated in basal media. In
vivo constructs were
qualitatively observed to stain
less intensely for Sox9-positive
cells compared with the staining
observed for constructs cultured
in vitro (BC basal culture, CC
chondrogenic culture, HBMSCs
human bone marrow stromal
cells). Bars 1 mm
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HBMSCs, neonatal articular chondrocytes and adult
chondrocytes for indications of optimal chondrogenic po-
tential (Table 1). We have previously documented the
three cell types as having different doubling times with
the immature cell type (neonatal articular chondrocytes)
being the most proliferative of the three cell types and
HBMSCs having the longest doubling time. In order to be
in tune with current cell processing methodologies in the
clinic, a cell type with a short doubling time is preferred in
order to prevent de-differentiation during monolayer expan-
sion (Saha et al. 2010). High alkaline-phosphatase-specific
activity (ALPSA) levels in chondrocytes indicate a shift from
Fig. 7 Aggrecan
immunostaining of in vivo
diffusion-chamber-cultured
constructs. Positive staining for
aggrecan (arrows, brown) was
observed in all samples with
varying intensities after in vivo
implantation intra-peritoneally
in nude mice for 3 (a–f) or
6 weeks (g–l). Constructs pre-
cultured in chondrogenic media
stained more intensely for
aggrecan compared with
constructs pre-incubated in
basal media. Similarly high
staining intensities were
observed in chondro-induced
neonatal and adult chondrocyte
constructs implanted in vivo for
6 weeks (BC basal culture, CC
chondrogenic culture, HBMSCs
human bone marrow stromal
cells). Bars 1 mm
Table 1 Comparing and contrasting chondrogenic potential across
three human cell types. A rapid visual summary of the observations
for a number of specific parameters indicating optimal chondrogenic
potential, which is scored qualitatively: a score of +, ++ and +++
indicates least, moderate and most ideal cell type, respectively, for the
particular parameters being analysed (HBMSCs human bone marrow
stromal cells, ALPSA alkaline-phosphatase-specific activity, qPCR
quantitative polymerase chain reaction, 3D three-dimensional)
Parameters (reference) HBMSCs Neonatal articular
chondrocytes
Adult articular
chondrocytes
Doubling time (Saha et al. 2010) + +++ +++
ALPSA (Saha et al. 2010) ++ + +++
Aggrecan; qPCR and immunohistochmistry (Saha et al. 2010) + +++ ++
Alcian Blue/Sirius Red staining of 3D constructs cultured
in chondrogenic media in vitro
• 3 weeks +++ + ++
• 6 weeks + +++ ++
Alcian Blue/Sirius Red staining of 3D constructs pre-incubated
in basal media and cultured in vivo
• 3 weeks + + +
• 6 weeks – – +
Effect of iron oxide incorporation on chondrogenic potential after
long-term culture (Saha et al. 2012)
+++ + +++
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the proliferative/pre-hypertrophic phase to a hypertrophic dif-
ferentiation state. Under ordinary basal culture, HBMSCs
(default osteogenic potential) exhibit high ALPSA levels,
whereas adult chondrocytes have the lowest ALPSA levels.
For the purpose of cartilage cell therapy, a cell type with a low
default ALPSA is preferred.
Human neonatal cartilage, unlike mature cartilage, is
known to contain two types of chondrocytes (Hwang
1978). A lack of understanding exists with respect to the
purpose of the two types of chondrocytes in immature
cartilage but we have shown there to be considerable
differences in chondrogenic gene regulation mechanisms
between immature and mature human chondrocytes (Saha
et al. 2010, 2012). Neonatal articular chondrocytes cul-
tured in chondrogenic medium have been seen to have the
highest level of collagen type II gene expression (a key
chondrogenic marker) compared with the other two cell
types. This difference in their gene expression might be
related to the differences observed at a histological level
as, in a 3D construct in vitro, these cells reveal the
thinnest fibrous capsule (indicative of a more hyaline-
like tissue formation) of the three cell types.
Before in vivo implantation, the samples were allowed
1 week for CCA, with one group additionally being provid-
ed with chondro-inductive cues. After in vivo implantation,
only the mature chondrocyte constructs formed a cartilage-
like tissue with the thinnest fibrous capsule. In the absence
of chondro-inductive cues, only the adult chondrocyte group
was capable of forming a tissue, although it was fibrous in
nature. This in vivo outcome is most likely to have occurred
because differentiated mature chondrocytes are able to
maintain their chondrogenic/pre-hypertrophic phenotype
with chondro-inductive cues provided by TGF-β3 in the
culture medium. We have previously shown that the addi-
tion of TGF-β3 in our chondrogenic culture medium de-
creases cartilage catabolic effects and helps maintain a pre-
hypertrophic chondrogenic phenotype while inducing
chondrogenesis in HBMSCs (Saha et al. 2010). Evidence
has been presented that aggrecan is co-expressed with Sox9
across all three cell types (Saha et al. 2010; Sengers et al.
2007; Shukunami et al. 1997; Tare et al. 2005). In this study,
we have confirmed these data via immunohistochemistry in
3D cultures, both in vitro and in vivo. This is a direct
consequence of Sox9 promoting the gene expression of
cartilage-type ECM by binding to the promoter elements
of aggrecan (Saha et al. 2010).
The TGF-β3 in the culture medium only helps to differ-
entiate the de-differentiated immature chondrocytes and
undifferentiated HBMSCs. It is unable to maintain the
chondrogenic phenotype of these two cell populations dur-
ing long-term culture in vivo. In a controlled in vitro envi-
ronment, e.g., after 6 weeks culture in chondrogenic
medium, neonatal chondrocyte constructs successfully form
structures that mimic native articular cartilage, with minimal
fibrous tissue formation, to a greater extent than is seen for
the other cell types. However, under in vivo conditions,
even chondro-induced neonatal articular chondrocytes fail
to retain a hyaline-like structure.
In the field of cartilage tissue engineering, confusion still
surrounds the difference between chondrogenic induction and
the maintenance of the chondrocyte phenotype. Differences in
the ability of TGF-β3 to maintain a chondrogenic phenotype
in HBMSCs and neonatal articular chondrocytes can be at-
tributed to a difference in the pattern of the temporal gene
expression of key chondrogenic markers when the cells are
cultured with this growth factor (Saha et al. 2010) or when
they are cultured with medium containing metal ions (Saha et
al. 2012). Smad2/3 has been reported to bind to Sox9 in a
manner dependent upon TGF-β to form transcriptional com-
plexes that enhance chondrogenesis (Furumatsu et al. 2005).
The threshold level of TGF-β that impacts on relevant
chondrogenic genemarkers is not known and, possibly, higher
concentrations of the growth factor help maintain the
chondrogenic phenotype of neonatal articular chondrocytes
and HBMSCs for a longer duration.
Our research highlights the need for a better under-
standing between chondro-inductive factors and those
factors that support the maintenance of a chondrogenic
phenotype. Furthermore, our results emphasise the im-
portance of sustained growth factor incorporation for the
maintenance of a chondrocyte-like phenotype in imma-
ture chondrocytes or undifferentiated HBMSCs.
In conclusion, this study has provided evidence that (1) the
chondrogenic medium used enhances cartilage matrix forma-
tion in vitro and in vivo but, although supporting the differen-
tiation of HBMSCs, is unable to maintain their chondrogenic
phenotype in long-term cultures; (2) the same inductive medi-
um is capable of maintaining the chondrogenic phenotype of
adult chondrocytes in long-term cultures but not of neonatal
chondrocytes; (3) immature (neonatal) chondrocytes appear to
be highly dependent on chondro-inductive growth factors for
the formation and maintenance of the cartilage phenotype, both
in short-term and in long-term cultures. Thus, under
chondrogenic culture conditions, adult chondrocytes appear
to be a more promising cell source than HBMSCs for use in
articular cartilage tissue engineering.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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